USP releases MEDMARX data report
In its sixth annual MEDMARX Report, USP examined medication errors associated with radiological services. According to the report, 12% of all med errors reported to MEDMARX occurring in conjunction with radiological services were rated as harmful errors-seven times that seen in the general MEDMARX dataset of reported errors. Since more than 300 million diagnoses and treatments each year utilize radiological services, including radiology departments, cardiac catheterization laboratories, and nuclear medicine, USP hopes that the report will spur self-examination at institutions to identify weak links within each facility. However, the report has been criticized by the American College of Radiology as incomplete and inaccurate, and the college fears that the report may cause unnecessary alarm from patients.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
